EU Proposes To Chop EMA Committees, Drop Five-Year Renewals
The EMA, Not The Commission, Would Decide On Orphan Designation
The EU’s legislative revision proposals include stripping down the European Medicines Agency’s committee structure, abolishing the five-yearly marketing authorization renewal requirement, and doing away with the “sunset clause” that requires a product to be launched in at least one EU country within three years of approval.
